跳至主要内容
临床试验/ACTRN12619000159156
ACTRN12619000159156招募中未知

Randomised controlled trial into the acceptability and effect of My Quit Buddy smartphone app on the self-reported quit rate in smokers

The Prince Charles Hospital0 个研究点目标入组 60 人开始时间: 2019年2月4日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult smokers (regular daily or non-daily use) able to give informed consent who own a smartphone capable of using the app and have access to a computer.

排除标准

  • Smokers who do not own a smartphone and/or do not have access to a computer. Smokers who are current users of a smoking cessation smart phone app.

研究者

相似试验

招募中
Unknown
Acceptability and Efficacy of Remote Treatment for Social Anxiety DisorderMental Health - AnxietySocial Anxiety Disorder
ACTRN12623000313639niversity of Technology Sydney78
已完成
不适用
Randomized controlled trial on the feasibility and safety of "Underwater endoscopic mucosal resection with injection" versus "conventional endoscopic mucosal resection" for superficial nonampullary duodenal epithelial tumorsSuperficial nonampullary duodenal epithelial tumor
JPRN-UMIN000041265agasaki University22
进行中(未招募)
1 期
Randomised controlled trial of the tolerability and completion of maraviroc compared to Kaletra© in combination with Truvada© for HIV post-exposure prophylaxisProphylaxis and prevention of HIV Infection.MedDRA version: 14.1 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestations
EUCTR2011-003447-21-GBCamden Provider Services213
招募中
不适用
A prospective randomized trial of acceptability, safety and feasibility comparing transnasal and peroral ultrathin endoscopy using GAGLESS mouthpiecesgastrointestinal disease
JPRN-UMIN000036922Medical corporation Irisawa Medical Clinic100
尚未招募
不适用
Randomized controlled trial to evaluate the feasibility and effectiveness of anti-adherent agent [Guardix-SG®(Poloxamer/alginate)] after inguinal herniorrhaphy (pilot study)Diseases of the digestive system
KCT0007398The Catholic University of Korea, St. Vincent's Hospital60